CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 15,419	$ 10,461
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sale of businesses and purchase of other assets	(49)	(2,724)
Impairment of goodwill	0	1,180
Loss on early extinguishment of debt	0	1,042
Depreciation and amortization	10,124	8,801
Amortization of deferred financing costs	688	681
Accretion of discount on convertible subordinated notes	2,554	1,647
Provision for losses on accounts receivable	1,332	2,113
Stock-based compensation expense	3,448	3,702
Deferred income tax (benefit) expense	2,065	(140)
Loss on redemption of convertible junior subordinated debentures	0	2,932
Changes in operating assets and liabilities that provided (required) cash:
Accounts and preneed receivables	(779)	(1,700)
Inventories and other current assets	3,277	725
Deferred charges and other	114	(196)
Preneed funeral and cemetery trust investments	21,234	(3,228)
Accounts payable	368	785
Accrued and other liabilities	4,408	(1,362)
Deferred preneed funeral and cemetery revenue	432	335
Deferred preneed funeral and cemetery receipts held in trust	(21,647)	2,595
Net cash provided by operating activities	42,988	27,649
Cash flows from investing activities:
Acquisitions and land for new construction	(4,250)	(56,850)
Purchase of Land and Buildings Previously Leased	(6,080)	(7,600)
Net proceeds from the sale of businesses and other assets	65	1,927
Capital expenditures	(22,823)	(10,558)
Net cash used in investing activities	(33,088)	(73,081)
Cash flows from financing activities:
Net borrowings on the revolving credit facility	22,500	5,400
Net borrowings (payments) on the term loan	(7,032)	5,656
Proceeds from the issuance of convertible subordinated notes	0	143,750
Payment of debt issuance costs related to the convertible subordinated notes	0	(4,650)
Payments on other long-term debt and obligations under capital leases	(679)	(662)
Redemption of convertible junior subordinated debentures	0	(89,748)
Payments for performance-based stock awards	0	(16,150)
Proceeds from the exercise of stock options and employee stock purchase plan contributions	575	1,035
Dividends on common stock	(1,385)	(1,379)
Payment of loan origination costs related to the credit facility	(13)	(825)
Purchase of treasury stock	(23,940)	0
Excess tax benefit of equity compensation	57	4,594
Net cash provided by (used in) financing activities	(9,917)	47,021
Net increase (decrease) in cash and cash equivalents	(17)	$ 1,589
Cash and cash equivalents at beginning of period	413
Cash and cash equivalents at end of period	$ 396